It’s great to be here at the Dutch Revascularization & Electrophysiology Summit (DRES Meeting) in Nijkerk, The Netherlands today Thursday 8th and tomorrow Friday 9th June 2023.
In this interview, we speak with Risco van Vliet, Master-of-Science Nurse practitioner at Dutch EMS ‘RAV Brabant Midden West Noord’. Six months ago he started as Project manager at Diagram Research managing pre-hospital trials.
We’re proud to announce that our organisation once again received the NEN-EN-ISO 9001:2015 – quality management system certification. We’re committed to quality and have been complying with the ISO 9001 standard for more than 16 years.
On 1 November, ACRON (Association for Contract Research Organisations in the Netherlands) organised their Autumn 2022 meeting.
We spent an interesting afternoon exchanging views on ‘Digitisation in health care’ and how this development is influencing the clinical research field.
On Saturday 22nd at EuroThrombosis & EuroVessels 2022 in Lisbon, Dr. Sem A.O.F. Rikken presented:
'Zalunfiban (RUC-4) and Pre-procedural Patency of the Infarct-related Artery in ST-Elevation Myocardial Infarction; insights from the Phase IIa study. Oral Abstract No 53, Cardiovascular Research 2022 Volume 118, Supplement 2, 22 Oct 2022.'
Using ICT to improve outcomes in patients, digital health (eHealth in short) makes health care more effective, affordable and more manageable.
As a research organisation, we’re working to get eHealth widely recognised by clearly demonstrating its added value through clinical trials and studies.
It’s been an inspiring couple of days, participating in ESC 2022 in Barcelona, Spain.
At the world’s largest gathering of cardiovascular professionals, we were treated to an outstanding program revealing the hottest science in cardiovascular medicine.
Dr. G.E. Cramer has defended his PhD thesis ‘Versatile Aspects of Cardiac Troponin Assessment: Innovative Clinical Settings, Coronary Sinus Sampling, and Qualitative Analyses’ on 20th May 2022 at the Radboud University Medical Centre, Nijmegen, the Netherlands.
To mark this glorious milestone, we briefly caught up with Etienne about his research.
